• Health & Medicine

CRT, University of Manchester and AstraZeneca work together to seek new cancer drugs

CANCER RESEARCH TECHNOLOGY, the commercial arm of Cancer Research UK, the University of Manchester and AstraZeneca today announced two agreements to seek new cancer drugs. CANCER RESEARCH TECHNOLOGY, the commercial arm of Cancer Research UK, the University of Manchester and AstraZeneca today announced two agreements to seek new cancer drugs.

14 June 2013

• Science & Technology
• Health & Medicine

'Treatment alliance' needed to save more children's lives from cancer

Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children. Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.

6 October 2012

• Health & Medicine

Channel 4 & Cancer Research UK to launch 'Stand Up To Cancer' in the UK

Channel 4 and Cancer Research UK are joining forces to launch ‘Stand Up To Cancer’ in the UK. Television, music and film stars will come together in October in a new national fundraising event to galvanise the public in the fight against cancer. The on-air season will build over a whole week on Channel 4, culminating in a live fundraising entertainment extravaganza. Channel 4 and Cancer Research UK are joining forces to launch ‘Stand Up To Cancer’ in the UK. Television, music and film stars will come together in October in a new national fundraising event to galvanise the public in the fight against cancer. The on-air season will build over a whole week on Channel 4, culminating in a live fundraising entertainment extravaganza.

23 August 2012

• Health & Medicine

Cancer Research UK receives largest ever donation

Cancer Research UK has been given a gift of Ј10 million from one of its supporters. This is the largest one-off donation the charity has ever received, and comes alongside an additional gift of Ј10 million from the same donor for the University of Southampton. Cancer Research UK has been given a gift of Ј10 million from one of its supporters. This is the largest one-off donation the charity has ever received, and comes alongside an additional gift of Ј10 million from the same donor for the University of Southampton.

18 July 2012

• Health & Medicine

Master switch’ experimental drug could treat different cancers

A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today. A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today.

10 July 2012

• Science & Technology
• Health & Medicine

Study points to potential new treatment for deadly pancreatic cancer

New research shows how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer. New research shows how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer.

29 April 2012

• Health & Medicine

Drug boosts survival when breast cancer spreads to brain

Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published today in the British Journal of Cancer. Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published today in the British Journal of Cancer.

30 November 2011

• Health & Medicine

'Glow in the dark' brains aid tumour surgery

A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK. A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK.

1 November 2011

• Health & Medicine

Cancer Research UK launches trial to treat brain cancer which has returned

Cancer Research UKїs Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer. Cancer Research UKїs Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

7 September 2011

• Health & Medicine
• Science & Technology

Projects launched to crack the cancer code

CANCER RESEARCH UK today launched two pioneering projects to identify the key genetic faults that are driving oesophageal and prostate cancers, which will transform our understanding of the diseases and pave the way to better and more targeted treatments. CANCER RESEARCH UK today launched two pioneering projects to identify the key genetic faults that are driving oesophageal and prostate cancers, which will transform our understanding of the diseases and pave the way to better and more targeted treatments.

13 July 2011

• Health & Medicine

Blocking key cell component could make 'smart drugs' effective for many cancer patients

Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors. The research is published in Nature Medicine today. Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors. The research is published in Nature Medicine today.

26 June 2011

• Health & Medicine

Cancer Research UK and CRT sign deal with Centella Therapeutics, inc to launch clinical development of radiotherapy-enhancing drug

Cancer Research UK and Cancer Research Technology, the charity's development and commercialisation arm, have partnered with Centella Therapeutics, Inc. of Palo Alto, California, to develop, manufacture and trial a promising new drug, CEN-209 in cancer patients with solid tumours. Cancer Research UK and Cancer Research Technology, the charity's development and commercialisation arm, have partnered with Centella Therapeutics, Inc. of Palo Alto, California, to develop, manufacture and trial a promising new drug, CEN-209 in cancer patients with solid tumours.

25 May 2011